GPX4 and neoplasm: For example, Zhao et al. developed a micellar delivery nano-drug, called DHM@RSL3, to release RSL3 in the hypoxia environment around the tumor, suppressed GPX4 protein expression with site-selectivity, and induced ferroptosis (Guo et al., 2020).